Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA launches new priority review voucher program for select biopharmas
Harvard University
Research
Turkish bank invests $39M in Harvard next-gen obesity antibodies
Once the antibodies are ready, a new biotech called Enlila will launch and may license them for clinical development.
Darren Incorvaia
Jun 16, 2025 1:07pm
Trump admin cuts $450M more from Harvard funding
May 13, 2025 1:33pm
Harvard sues Trump admin over threats to freeze research funds
Apr 22, 2025 10:54am
NIH directed not to inform universities about freezes: reports
Apr 21, 2025 11:59am
Trump freezes more than $2B to Harvard as school defies admin
Apr 15, 2025 11:55am
Princeton, Harvard join peers in facing federal funding cuts
Apr 2, 2025 1:45pm